glp 1 drugs and crohn's disease GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Ozempic and Crohn's Disease: Could

Toxins 6 , 934949 (2014)

In short, they are reported to increase the growth of intestinal epithelial cells, enhance intestinal barrier function, influence immune cell development and populations in the gut-associated lymphoid tissue, exert anti-inflammatory and potentially T H 1 promoting and/or T H 2 inhibiting effects on various intestinal immune cells, and modify the abundance of gut microbiota that might play a role in allergic sensitization (Figure 1)

The evidence increasingly suggests that these medications work best as long-term treatments rather than short-term interventions

A., Silva, J

Additionally, there is growing interest in the potential systemic benefits of transdermal glutathione